About PRECOS
PRECOS is a company based in United Kingdom founded in 2010 was acquired by Crown Bioscience in July 2013.. The company has 8 employees as of May 31, 2021. PRECOS operates in a competitive market with competitors including Orakl Oncology, Oncodesign, Orange Grove Bio LLC, Lytica Therapeutics and LumaBridge, among others.
- Headquarter United Kingdom
- Employees 8 as on 31 May, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Proweb (Uk) Limited
- Date of Incorporation 21 Feb, 1996
- Jurisdiction NOTTINGHAM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
8
as on May 31, 2021
-
Acquired by
Crown Bioscience
(Jul 30, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PRECOS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PRECOS
PRECOS has secured backing from 1 investor. Prominent investors backing the company include Crown Bioscience. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cancer and CVMD drugs are developed using PDX models.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PRECOS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PRECOS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Precos Comparisons
Competitors of PRECOS
PRECOS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orakl Oncology, Oncodesign, Orange Grove Bio LLC, Lytica Therapeutics and LumaBridge, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Orakl Oncology is a precision oncology start-up that enables the emergence of rare oncology by connecting patient tumors to the world's 3rd best cancer center.
|
|
| domain | founded_year | HQ Location |
Preclinical assessment services for anti-cancer therapies are provided.
|
|
| domain | founded_year | HQ Location |
Provider of preclinical development services
|
|
| domain | founded_year | HQ Location |
Therapeutic drugs are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Provider of oncology clinical research, regulatory affairs, and data management services
|
|
| domain | founded_year | HQ Location |
Developer of immune assays for the diagnosis of cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about PRECOS
When was PRECOS founded?
PRECOS was founded in 2010.
Where is PRECOS located?
PRECOS is headquartered in United Kingdom.
How many employees does PRECOS have?
As of May 31, 2021, the latest employee count at PRECOS is 8.
What does PRECOS do?
PRECOS was founded in 2010 in the United Kingdom, focusing on the oncology drug development sector. Preclinical services, including patient-derived xenograft, orthotopic, and metastatic modeling along with imaging, were delivered. Models that mirrored cancer progression stagessuch as pre-cancerous lesions, primary tumors, and metastasiswere employed to support research. Acquisition by Crown Bioscience occurred in 2013.
Who are the top competitors of PRECOS?
PRECOS's top competitors include Oncodesign, Orakl Oncology and Lytica Therapeutics.
Who are PRECOS's investors?
PRECOS has 1 investor. Key investors include Crown Bioscience.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.